Recently, the "Jingxi Talk" hosted by Yiou Health was held in Beijing. The CHS 2023 China Health Industry Innovation List was released at the meeting. After more than three months of collection and selection,  high-quality pharmaceutical companies in the industry such as RainMed Medical and JD Health, etc. stood out and were named "Top 10 Enterprises with Investment Value in China's Big Health Industry in 2023" . As a domestic independent innovation enterprise, RainMed Medical has an outstanding R&D innovation and strong marketing capabilities after years of accumulation, which have laid a solid foundation for further development and won investors and analysts’ high recognition and evaluation.

Since its establishment, RainMed Medical has established the strategic goal of "creating cutting-edge vascular interventional surgery robots", implemented the strategic plan step by step, and quickly launched a number of revolutionary products in the field of precision medicine,including: caFFR system, the most accurate functional diagnostic product in China; caIMR system, the world's first non-invasive coronary microcirculation diagnostic product; FlashBot, the first vascular interventional surgery robot in China that covers the entire diagnosis and treatment process; Flash, a cutting-edge treatment product for coronary artery calcification. IVL shock wave balloon, etc. In just four years since its commercialization, the company's products have been used in more than 1,000 hospitals in 30 provinces, municipalities and autonomous regions in China as well as in 15 foreign countries and regions. We have built a global marketing network and provided precise medical solutions for patients with vascular diseases .

We are encouraged by mainstream platforms and industry experts’ recognition of the company’s value in promoting industrial innovation. In the future, RainMed Medical will continue to uphold the original intention and mission of “targeted medical services for the people’s Health”, reward doctors and patients with innovation, return on  invested capital, and contribute to the development of the medical and health industry!